These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The effects of atrial natriuretic peptide on urinary protein excretion in patients with renal parenchymal disease and those with diabetic mellitus]. Fukui K; Hirata Y; Kimura K; Sugimoto T; Matsuoka H; Ishii M; Sugimoto T Nihon Jinzo Gakkai Shi; 1990 Feb; 32(2):199-205. PubMed ID: 2141091 [TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome. Plum J; Mirzaian Y; Grabensee B Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965 [TBL] [Abstract][Full Text] [Related]
6. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats. Palluk R; Veress AT; Sonnenberg H Pharmacology; 1989; 38(4):214-25. PubMed ID: 2526952 [TBL] [Abstract][Full Text] [Related]
7. Effect of alpha-human atrial natriuretic peptide on proteinuria in patients with primary glomerular diseases. Ishi M; Hirata Y; Sugimoto T; Matsuoka H; Kimura K; Ishimitsu T; Fukui K; Sugimoto T; Kurosawa Y; Kiyose H Clin Sci (Lond); 1989 Dec; 77(6):643-50. PubMed ID: 2532580 [TBL] [Abstract][Full Text] [Related]
8. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate. Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB Nephron; 1995; 71(1):44-53. PubMed ID: 8538848 [TBL] [Abstract][Full Text] [Related]
9. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient]. Iannettone CM; Strazzulla G; Fabbri G; Piazza E; Valenza T; De Feo ML; Franchi F Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999 [TBL] [Abstract][Full Text] [Related]
10. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor. Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440 [TBL] [Abstract][Full Text] [Related]
11. Renal effects of ANP without changes in glomerular filtration rate and blood pressure. Salazar FJ; Fiksen-Olsen MJ; Opgenorth TJ; Granger JP; Burnett JC; Romero JC Am J Physiol; 1986 Sep; 251(3 Pt 2):F532-6. PubMed ID: 2944393 [TBL] [Abstract][Full Text] [Related]
12. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading. Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440 [TBL] [Abstract][Full Text] [Related]
13. Role of angiotensin II in the renal response to atrial natriuretic peptide in normal subjects. Rakugi H; Ogihara T; Nakamaru M; Saito H; Shima J; Sakaguchi K; Kumahara Y J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S55-8. PubMed ID: 2473352 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200 [TBL] [Abstract][Full Text] [Related]
15. Suppression of the natriuretic effects of exogenous atrial natriuretic peptide in animals with total artificial hearts. Mabuchi K; Hayakawa H; Hirata Y; Iizuka M; Imachi K; Chinzei T; Nozawa H; Abe Y; Yonezawa T; Suzukawa M ASAIO Trans; 1991; 37(3):M214-6. PubMed ID: 1661120 [TBL] [Abstract][Full Text] [Related]
16. Renal effects of atrial natriuretic peptide infusion in young and adult rats. Chevalier RL; Gomez RA; Carey RM; Peach MJ; Linden JM Pediatr Res; 1988 Sep; 24(3):333-7. PubMed ID: 2850523 [TBL] [Abstract][Full Text] [Related]
17. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease. Taira K; Hewitson TD; Kincaid-Smith P Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068 [TBL] [Abstract][Full Text] [Related]
18. Effect of atrial natriuretic peptide on the release of rat renal kallikrein. Klein HG; Schöneck V; Obika LF; Odigie P; Angchanpen P; Marin-Grez M Miner Electrolyte Metab; 1989; 15(3):130-6. PubMed ID: 2524641 [TBL] [Abstract][Full Text] [Related]